FDA approves 23andMe gene carrier test

被引：0

|

作者：

不详

机构：

来源：

NATURE BIOTECHNOLOGY | 2015年 / 33卷 / 05期

关键词：

D O I：

暂无

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

引用

收藏

页码：435 / 435

页数：1

相关论文

共 50 条

[31] Algorithmic Abstraction and the Racial Neoliberal Rhetorics of 23andMe
Weisse, Kathleen Daly
Jung, Julie
Sharp-Hoskins, Kellie
[J]. RHETORIC REVIEW, 2021, 40 (03) : 284 - 299
[32] 23andMe disease risk tests OK'd
不详
[J]. SCIENCE, 2017, 356 (6334) : 116 - 116
[33] PHARMACEUTICALS GSK, 23andMe to apply genetics to drug discovery
Cross, Ryan
[J]. CHEMICAL & ENGINEERING NEWS, 2018, 96 (31) : 14 - 14
[34] Individual DNA samples and health information sold by 23andMe
Adam, Shelin
Friedman, Jan M.
[J]. GENETICS IN MEDICINE, 2016, 18 (04) : 305 - 306
[35] Innovation, Risk, and Patient Empowerment The FDA-Mandated Withdrawal of 23andMe's Personal Genome Service
Downing, Nicholas S.
Ross, Joseph S.
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2014, 311 (08): : 793 - 794
[36] 23andMe, the Food and Drug Administration, and the Future of Genetic Testing
Zettler, Patricia J.
Sherkow, Jacob S.
Greely, Henry T.
[J]. JAMA INTERNAL MEDICINE, 2014, 174 (04) : 493 - 494
[37] 23andMe launches a giant weight-loss study
Regalado, Antonio
[J]. MIT TECHNOLOGY REVIEW, 2018, 121 (02): : 18 - 18
[38] Association of Sickle Cell Trait and Venous Thromboembolism in the 23andMe Cohort
Lin, Keng-Han
Granka, Julie M.
Shastri, Anjali
Bonham, Vence L.
Naik, Rakhi P.
[J]. BLOOD, 2022, 140 : 1962 - 1962
[39] 23andMe markets carrier screening service directly to consumers: Service offers results on carrier status, raises concerns among geneticists
Levenson, Deborah
[J]. AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2016, 170 (02) : 293 - 294
[40] 23andMe: how to make (a lot of) money out of your customers
Jordan, Bertrand
[J]. M S-MEDECINE SCIENCES, 2015, 31 (04): : 447 - 449

← 1 2 3 4 5 →